K
Katherine Cianflone
Researcher at Laval University
Publications - 253
Citations - 13040
Katherine Cianflone is an academic researcher from Laval University. The author has contributed to research in topics: Acylation stimulating protein & Adipose tissue. The author has an hindex of 62, co-authored 252 publications receiving 12486 citations. Previous affiliations of Katherine Cianflone include Huazhong University of Science and Technology & Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects
TL;DR: Changes in ASP and adiponectin are predictive of decreased apolipoprotein B and improved insulin action, respectively, and plasma ghrelin increases after gastric bypass surgery in patients experiencing active weight loss.
Journal ArticleDOI
Functional roles for C5a receptors in sepsis
Daniel Rittirsch,Michael A. Flierl,Brian A. Nadeau,Danielle E. Day,Markus Huber-Lang,Charles R. Mackay,Firas S. Zetoune,Norma P. Gerard,Norma P. Gerard,Katherine Cianflone,Jörg Köhl,Jörg Köhl,Craig Gerard,J. Vidya Sarma,Peter A. Ward +14 more
TL;DR: In this paper, the role of C5a receptors in the setting of cecal ligation and puncture-induced sepsis was investigated by using antibody-induced blockade of C 5a receptors and knockout mice.
Journal ArticleDOI
Critical review of acylation-stimulating protein physiology in humans and rodents
TL;DR: A comprehensive overview of the recent literature on acylation-stimulating protein is provided, with particular emphasis on those studies carried out in rodents and humans.
Journal ArticleDOI
Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2
Olivier Le Bacquer,Emmanuel Petroulakis,Sabina Paglialunga,Francis Poulin,Denis Richard,Katherine Cianflone,Nahum Sonenberg +6 more
TL;DR: The role of 4E-BPs as a metabolic brake in the development of obesity is clearly demonstrated and the idea that deregulated mTOR signaling is associated with theDevelopment of the metabolic syndrome is reinforced.
Journal ArticleDOI
Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus
TL;DR: Physicians should understand hypertriglyceridemic hyperapoB pathophysiology in order to better select and monitor therapy.